Overview
EXEL market data
Price History
EXEL price chart
Valuation & Profitability
- P/E (TTM)
- 14.54 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.78 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.45 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 35.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $33.76 – $57.57 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $12.5B · P/B 5.44 · P/S 5.14.
Company News
Truist Securities Maintains Hold on Exelixis, Lowers Price Target to $52Benzinga · Aug 6, 2026, 4:00 PM
Stifel Maintains Hold on Exelixis, Raises Price Target to $51Benzinga · Aug 6, 2026, 2:17 PM
Exelixis shares are trading lower after the company reported mixed Q2 financial results and cut its FY26 sales guidance below estimates.Benzinga · Aug 6, 2026, 11:29 AM
Exelixis Lowers FY2026 Sales Guidance from $2.525B-$2.625B to $2.500B-$2.550B vs $2.595B EstBenzinga · Aug 5, 2026, 8:23 PM
Exelixis Q2 Adj. EPS $0.91 Beats $0.79 Estimate, Sales $628.700M Miss $635.951M EstimateBenzinga · Aug 5, 2026, 8:08 PM
Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law FirmGlobenewswire Inc · Jul 29, 2026, 11:31 PM
Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53Benzinga · Jul 23, 2026, 6:03 PM
Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49Benzinga · Jul 14, 2026, 11:03 AM
Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49Benzinga · Jul 13, 2026, 2:25 PM
RBC Capital Maintains Sector Perform on Exelixis, Raises Price Target to $46Benzinga · Jul 7, 2026, 4:20 PM